Literature DB >> 9495349

Transcript levels of aquaporin 1 and carbonic anhydrase IV as predictive indicators for prognosis of renal cell carcinoma patients after nephrectomy.

J Takenawa1, Y Kaneko, M Kishishita, H Higashitsuji, H Nishiyama, T Terachi, Y Arai, O Yoshida, M Fukumoto, J Fujita.   

Abstract

Since failure of differentiation has been suggested to be involved in the neoplastic process and progression of tumors, we evaluated whether the transcript levels of differentiation markers of proximal renal tubular cells, from which renal cell carcinoma (RCC) arises, could be used as prognostic markers. We used Northern blot analysis to study the expression of aquaporin 1 (aqp1) and carbonic anhydrase IV (ca4) genes in 66 paired samples of primary RCC and non-tumorous kidney tissues. Poor differentiation of tumor cells and non-clear cell-subtype RCC were significantly associated with low levels of aqp1 transcripts. When patients were divided into 2 groups according to level of aqpI transcript in RCC, a low level of aqp1 was significantly associated with unfavorable outcome. Among 18 patients with metastatic RCC and 40 patients with moderately differentiated RCC, those with RCC expressing low levels of aqpl mRNA demonstrated poorer survival than those with RCC expressing relatively high levels of aqp1. Similarly, decreased expression of ca4 mRNA in RCC was associated with poor survival. On multivariate analysis, transcript levels of aqpI and stage of the tumor were the independent factors predicting disease-specific survival. Transcript levels of aqp1 may serve as a new molecular prognostic marker in patients with RCC following nephrectomy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495349     DOI: 10.1002/(sici)1097-0215(19980220)79:1<1::aid-ijc1>3.0.co;2-5

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid.

Authors:  K Birkenkamp-Demtroder; S H Olesen; F B Sørensen; S Laurberg; P Laiho; L A Aaltonen; T F Orntoft
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 2.  Potential biofluid markers and treatment targets for renal cell carcinoma.

Authors:  Hiromi I Wettersten; Robert H Weiss
Journal:  Nat Rev Urol       Date:  2013-04-02       Impact factor: 14.432

3.  Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma.

Authors:  Kimiya Sato; Morikazu Miyamoto; Masashi Takano; Kenichi Furuya; Hitoshi Tsuda
Journal:  Pathol Oncol Res       Date:  2018-07-19       Impact factor: 3.201

4.  Urinary biomarkers for the early diagnosis of kidney cancer.

Authors:  Jeremiah J Morrissey; Amy N London; Jingqin Luo; Evan D Kharasch
Journal:  Mayo Clin Proc       Date:  2010-04-07       Impact factor: 7.616

5.  Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer.

Authors:  Pedro M S Alves; Nicole Lévy; Brian J Stevenson; Hanifa Bouzourene; Grégory Theiler; Gabriel Bricard; Sebastien Viatte; Maha Ayyoub; Henri Vuilleumier; Jean-Claude R Givel; Donata Rimoldi; Daniel E Speiser; C Victor Jongeneel; Pedro J Romero; Frédéric Lévy
Journal:  Cancer Immun       Date:  2008-06-27

Review 6.  Aquaporins--new players in cancer biology.

Authors:  A S Verkman; Mariko Hara-Chikuma; Marios C Papadopoulos
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

7.  A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.

Authors:  Ren Liu; Yuanfa Feng; Yulin Deng; Zhihao Zou; Jianheng Ye; Zhiduan Cai; Xuejin Zhu; Yingke Liang; Jianming Lu; Hui Zhang; Yong Luo; Zhaodong Han; Yangjia Zhuo; Qingling Xie; Chi Tin Hon; Yuxiang Liang; Chin-Lee Wu; Weide Zhong
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07

8.  A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma.

Authors:  Guodong Shi; Jingjing Zhang; Zipeng Lu; Dongfang Liu; Yang Wu; Pengfei Wu; Jie Yin; Hao Yuan; Qicong Zhu; Lei Chen; Yue Fu; Yunpeng Peng; Yan Wang; Kuirong Jiang; Yi Miao
Journal:  Oncotarget       Date:  2017-12-02

9.  Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Authors:  Suraj Peri; Elena Caretti; Rossella Tricarico; Karthik Devarajan; Mitchell Cheung; Eleonora Sementino; Craig W Menges; Emmanuelle Nicolas; Lisa A Vanderveer; Sharon Howard; Peggy Conrad; James A Crowell; Kerry S Campbell; Eric A Ross; Andrew K Godwin; Anthony T Yeung; Margie L Clapper; Robert G Uzzo; Elizabeth P Henske; Christopher J Ricketts; Cathy D Vocke; W Marston Linehan; Joseph R Testa; Alfonso Bellacosa; Levy Kopelovich; Alfred G Knudson
Journal:  Oncotarget       Date:  2017-03-14

10.  Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode.

Authors:  Zhou Jiawei; Mu Min; Xing Yingru; Zhang Xin; Li Danting; Liu Yafeng; Xie Jun; Hu Wangfa; Zhang Lijun; Wu Jing; Hu Dong
Journal:  Front Mol Biosci       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.